文献速递肝病

基层医疗环境中脂肪性肝病不同亚型的患病率、分布及肝纤维化负担

Prevalence, distribution, and hepatic fibrosis burden of the different subtypes of steatotic liver disease in primary care settings.
PubMed 文献 · Hepatology · 2023-11-01

该回顾性研究纳入5家基层健康促进诊所健康体检中接受磁共振弹性成像和MRI质子密度脂肪分数检查的2535人,按新SLD分类评估。总队列SLD患病率为39.13%,其中MASLD为29.51%、MetALD为7.89%、ALD为0.39%;MetALD组平均磁共振弹性成像显著高于MASLD或ALD组。

要点

  • 总队列SLD患病率39.13%,95.77%的SLD病例存在代谢功能障碍。
  • MASLD患病率29.51%,MetALD为7.89%,ALD为0.39%。
  • MetALD组平均磁共振弹性成像显著高于MASLD或ALD组。

核心结论

  • 几乎所有NAFLD患者符合MASLD新标准。
  • MetALD组的纤维化负担高于MASLD和ALD组。

研究设计与样本

  • 回顾性收集5家基层健康促进诊所健康体检中接受磁共振弹性成像和MRI质子密度脂肪分数检查的2535人的数据。
  • 根据 predefined 标准评估心血管代谢危险因素,并按新SLD分类对全部参与者分组。

主要发现

  • 总队列SLD患病率为39.13%,95.77%的SLD病例有代谢功能障碍(一种或以上心血管代谢危险因素)。
  • MASLD患病率为29.51%,MetALD为7.89%,ALD为0.39%。
  • 按旧标准NAFLD患病率为29.11%,95.80%的NAFLD病例符合MASLD新标准。
  • SLD亚型分布以MASLD最高(75.40%),其次为MetALD(20.06%)、隐源性SLD(3.33%)和ALD(1.01%)。
  • MetALD组平均磁共振弹性成像显著高于MASLD或ALD组。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIM: In relation to the new umbrella terminology for steatotic liver disease (SLD), we aimed to elucidate the prevalence, distribution, and clinical characteristics of the SLD subgroups in the primary care setting. APPROACH AND RESULTS: We retrospectively collected data from 2535 individuals who underwent magnetic resonance elastography and MRI proton density fat fraction during health checkups in 5 primary care health promotion clinics. We evaluated the presence of cardiometabolic risk factors according to predefined criteria and divided all the participants according to the new SLD classification. The prevalence of SLD was 39.13% in the total cohort, and 95.77% of the SLD cases had metabolic dysfunction (one or more cardiometabolic risk factors). The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) was 29.51%, with those of metabolic dysfunction and alcohol associated steatotic liver disease (MetALD) and alcohol-associated liver disease (ALD) at 7.89% and 0.39%, respectively. According to the old criteria, the prevalence of NAFLD was 29.11%, and 95.80% of the NAFLD cases fulfilled the new criteria for MASLD. The distribution of SLD subtypes was highest for MASLD, at 75.40%, followed by MetALD at 20.06%, cryptogenic SLD at 3.33%, and ALD at 1.01%. The MetALD group had a significantly higher mean magnetic resonance elastography than the MASLD or ALD group. CONCLUSION: Almost all the patients with NAFLD met the new criteria for MASLD. The fibrosis burden of the MetALD group was higher than those of the MASLD and ALD groups.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Lee CM, Yoon EL, Kim M, et al. Prevalence, distribution, and hepatic fibrosis burden of the different subtypes of steatotic liver disease in primary care settings. Hepatology. 2023. PMID: 38100294. doi:10.1097/HEP.0000000000000664

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。